ArticleCancer prevention research (Philadelphia, Pa.)2026
Comparative Analysis of Breast and Cervical Screening Adaptability at a Federally Qualified Health Center.
Article in Cancer prevention research (Philadelphia, Pa.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Structural barriers to cancer screening at federally qualified health centers (FQHC) have contributed to lower screening rates than those among the broader populace, which were exacerbated by the COVID-19 pandemic. We apply the complex adaptive systems (CAS) theory to understand how one FQHC system in California reshaped its breast and cervical cancer screening programs to minimize health disruptions during the pandemic. This qualitative study, conducted between March 2022 and January 2023, consisted of interviews with clinic leadership and first-line staff, asking them to retrospectively reflect on the clinic's experiences with breast and cervical cancer screening delivery both immediately before and during the pandemic. Interviews were recorded and transcribed, and we performed content analysis and then applied the CAS theory. Participants (n = 20) ranged in age from 26 to 56 years, were mostly female (85%), and held leadership positions (65%). Participants indicated that cervical cancer screening rebounded more quickly than breast cancer screening programs. Results suggest that this difference could potentially be associated with new workflows that were in process prepandemic in the cervical cancer program to address existing screening barriers, as well as the FQHC's flexible approach to pandemic barriers, which included bolstering screening registries, hiring additional female providers, and bundling Pap smears into routine visits. In contrast, breast cancer screening relied on external radiology vendors, which may have reduced its flexibility to adjust to care disruptions. We highlight how healthcare delivery is shaped by interactions among diverse agents and nonlinear processes that occur in a dynamic and interconnected healthcare system. PREVENTION RELEVANCE: We apply the CAS theory to better understand the trajectory of FQHC preventive cancer screening programs during the COVID-19 pandemic. By extending beyond the identification of stand-alone barriers and facilitators, we highlight the ways in which healthcare delivery is shaped by interactions among diverse agents and nonlinear processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.